<DOC>
	<DOCNO>NCT00987376</DOCNO>
	<brief_summary>Prostate cancer image use traditional anatomic modality include CT , MR , ultrasound limited . Improvement current image modality development new one priority prostate cancer research . Optimal treatment varies considerably patient different stag characterization new image method accurately stage patient could lead appropriate treatment . The objective study obtain preliminary , comparative data new , promising image method prostate cancer . PET/CT image use 11C-choline,11C-acetate , Y86 18F-Adenosylcobalamin MRI spectroscopy ( MRS ) prostate cancer compare . Direct comparison image method never do Mayo Clinic Johns Hopkins uniquely able conduct trial inter-SPORE collaboration .</brief_summary>
	<brief_title>Novel PET/CT Agents MRS/MRI Prostate CA High Risk Prostate Cancer : An Inter-SPORE Collaboration</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Males 18 year age old Patients complete stag CT and/or bone scan part routine workup Patients bulky metastatic prostate cancer 5 lesion suspicious distant metastasis determine routine CT and/or bone scan untreated radiation Patients le 6 week post operative Greenfield filter placement Patients metallic surgical implant include pacemaker implant , cochlear implant , denture hold place magnet imbed gum aneurysm clip except inserted Mayo insert October 1994 /or metal fragment body include metal fragment eye</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>